QFINITY at the 5th Annual ACDM AI Symposium in London

On June 23 and 24, 2026, QFINITY participated in the 5th Annual ACDM AI Symposium in London – a gathering of experts from pharmaceutical companies, CROs, and technology providers on the growing role of artificial intelligence in clinical trials and clinical data management.

QFINITY participated in the 5th Annual ACDM AI Symposium, which took place on June 23 and 24, 2026, in London. The symposium brought together experts from pharmaceutical companies, CROs, and technology providers to discuss the growing role of artificial intelligence in clinical trials and clinical data management.

Over the course of two days, experts shared practical use cases and implementation strategies and offered perspectives on the adoption of AI across the entire clinical development process. The focus was on data quality, governance, and regulatory requirements – as well as the responsible integration of AI into clinical research workflows.

For QFINITY, the symposium was an opportunity to exchange ideas with industry peers, strengthen existing partnerships, and explore how AI-supported solutions can support more efficient and compliant clinical data management.